Division of Pathogenic Biochemistry
Staff Research Publication  

List of Publications

≪ Previous Year 2007 Next Year ≫

Books and Reviews

1) Sakurai H., and Saiki I.:
Anti-tumor activity of Juzentaihoto by modulating immune system.
The23rd annual meeting of medical and Pharmaceutical Society for WAKAN-YAKU (ed.),
Recent Advances in Wakanyaku (Japanese-Chinese traditional medicine) research in Japan and China. Funahashi Printing & Co. Ltd., Gifu, 2007, pp71-97.

2) Koizumi K., Hojo S., Akashi T., Yasumoto K., and Saiki I.:
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response

Cancer Sci., 98:1652-1658, 2007. [Abstract]
3) 櫻井宏明:
生化学, 79:883-887, 2007. [Abstract]
4) 済木育夫:
漢方と最新治療, 16:117-120, 2007.

Original Papers

1) Matsuo M., Sakurai H., Koizumi K., and Saiki I.:
Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells.

Cancer Lett., 251: 288-295, 2007. [Abstract]
2) Tsunoda S., Nakamura T., Sakurai H., and Saiki I.:
FGF-2-induced host stroma reaction during the initial tumor growth promotes progression of mouse melanoma via VEGFA-dependent neovascularization.

Cancer Sci., 98: 541-548, 2007. [Abstract]
3) Chuethong J., Oda K., Sakurai H., Saiki I., and Leelamanit W.:
Cochinin B, a novel ribosome-inactivating protein from the seeds of Momordica cochinchinensis.

Biol. Pharm. Bull., 30: 428-432, 2007. [Abstract]
4) Koizumi K., Kozawa Y., Ohashi Y., Nakamura E.S., Aozuka Y., Sakurai H., Ichiki K., Doki Y., Misaki T., and Saiki I.:
CCL21 promotes the migration and adhesion of highly metastatic human non-small cell lung cancer Lu-99 in vitro.
Oncol. Rep., 17:1511-1516, 2007. [Abstract]
5) Shambharkar P.B., Blonska M., Pappu B.P., You Y., Sakurai H., Darnay B., and Lin X.:
Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signaling pathways.

EMBO J., 26: 1794-1805, 2007. [Abstract]
6) Singhirunnusorn P., Ueno Y., Matsuo M., Suzuki S., Saiki I., and Sakurai H.:
Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-α through the TAK1-p38 pathway.

J. Biol. Chem., 282: 12698.12706, 2007. [Abstract]
7) Hojo S., Koizumi K., Tsuneyama K., Arita Y., Cui Z., Shinohara K., Minami T., Hashimoto I., Nakayama T., Sakurai H., Takano Y., Yoshie O., Tsukada K., and Saiki I.:
High level expression of chemokine CXCL16 by tumor cells correlated with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.

Cancer Res., 67: 4725-4731, 2007. [Abstract]
8) Igarashi Y., Trujillo M.E., Mart?nez-Molina E., Yanase S., Miyanaga S., Obata T., Sakurai H., Saiki S., Fujita T., and Furumai T.:
Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov.

Bioorg. Med. Chem. Lett., 17: 3702-3705, 2007. [Abstract]
9) Matsuo M., Yamada S., Koizumi K., Sakurai H., and Saiki I.:
Tumour-derived fibroblast growth factor-2 exerts lymphangiogenic effects through Akt/mTOR/p70S6kinase pathway in rat lymphatic endothelial cells.

Eur. J. Cancer, 43: 1748-1754, 2007. [Abstract]
10) Kammasud N., Grierson D., Tsunoda S., Sakurai H., Saiki I., and Vajragupta O.:
Novel inhibitor for fibroblast growth factor receptor tyrosine kinase.

Bioorg. Med. Chem. Lett., 17: 4812-4818, 2007. [Abstract]
11) Ogawa K., Kojima T., Matsumoto C., Kamegai S., Oyama T., Shibagaki Y., Kawasaki T., Fujinaga H., Takahashi K., Hikiami H., Goto H., Kiga C., Koizumi K., Sakurai H., Muramoto H., Shimada Y., Yamamoto M., Terasawa K., Takeda S., and Saiki I.:
Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients.

Clin. Biochem., 40: 1113-1121, 2007. [Abstract]
12) Suzuki S., Singhirunnusorn P., Mori A., Yamaoka S., Kitajima I., Saiki I., and Sakurai H.:
Constitutive activation of TAK1 by HTLV-1 Tax-dependent overexpression of TAB2 induces activation of JNK-ATF2, but not IKK-NF-κB.

J. Biol. Chem., 282: 25177-25181, 2007. [Abstract]
13) Nozaki K., Goto H., Nakagawa T., Hikiami H., Koizumi K., Shibahara N., and Shimada Y.:
Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats.

Biol. Pharm. Bull., 30: 1042-1047, 2007.
14) Saitoh Y., Koizumi K., Sakurai H., Minami T., and Saiki I.:
RANKL-induced down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cells.

Biochem. Biophys. Res. Commun., 364: 417-422, 2007.

▲Page top

Top page Study for cross roads of between natural medicine and cancer research
Division of Pathogenic Biochemistry
Institute of Natural Medicine, University of Toyama
2630 Suginoki, Toyama 930-0194, Japan

Top page University of Toyama Institute of Natural Medicine